Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0403608 (ureter)
 9,655 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

1. Following an oral dose of [14C]phenol (12.5 or 25 mg/kg) to sheep, pig and rat, urinary elimination of radioactivity was rapid, 80-90% dose being excreted in the first 8 h. 2. In anaesthetized, ureter-cannulated rats, 70-80% of an intraduodenal dose was eliminated in 2 h; 2% dose was excreted as phenol conjugates in the urine within 10 min. 3. The major urinary metabolites from phenol (25 mg/kg) were phenylglucuronide and phenylsulphate. In the sheep, pig and rat, the glucuronide accounted for 49%, 83% and 42% respectively, of the total urinary metabolites and sulphate accounted for 32%, 1% and 55%. Conjugates of quinol were minor urinary metabolites (less than 7%) in all three species. 4. In sheep some 12% of the urinary metabolites was conjugated with phosphate; this metabolite was not found in rat or pig.
 ...
PMID:Metabolism of [14C]phenol by sheep, pig and rat. 47 90

Focal necrosis of the ureter was observed in our patient 7 days after CT-guided chemical sympathectomy. The injection of phenol was apparently rendered remote from the ureter and still caused ureteric necrosis. Ureteric injury may thus result following chemical sympathectomy, not from direct puncture of the ureter, but from unpredictable individual diffusion pathways.
 ...
PMID:Focal necrosis of the ureter following CT-guided chemical sympathectomy. 162 85

Retroperitoneal fibrosis was induced in 30 rats by placing a paraffin pellet containing 5 mg of phenol-mandelic acid behind the left ureter. In an additional 15 rats, the left urinary tract was transposed into a silicone sheath before the pellet of phenol-mandelic acid was placed behind the ureter in an attempt to protect the urinary tract from retroperitoneal fibrosis. In all 30 animals without the sheath, hydronephrosis of the left side occurred, and in the 15 animals with the sheath, lateral and anterior displacement of the left tract occurred, but function was not impaired. It is concluded that the silicone-sheath technique may represent a new therapeutic approach to retroperitoneal fibrosis.
 ...
PMID:Microsurgical urology: a silicone cover to protect the ureter from induced retroperitoneal fibrosis in rats. 724 Oct 41

At present, the "therapy of choice" for patients presenting retroperitoneal fibrosis is uretrolysis with intraperitoneal transposition. This procedure, however, leaves the upper and lower part of the ureter vulnerable to recurrent fibrotic stricture since these portions still remain within the retroperitoneal space. In order to protect the ureter in its entire length from aggressive fibrosis an alloplastic cover might offer a better alternative. Following experimental induction of retroperitoneal fibrosis by phenol-mandelic acid in rats the entire ureter was displaced into a silicone envelope. Under the operating microscope the silicone sheath was closed around the renal pedicale by separate sutures of 8-0 prolene. The upper and lateral sealing of this pouch was done by continous sutres and the lower opening of this silicone envelope was fixed to the bladder wall. Progressive retroperitoneal fibrosis caused anterior displacement of the silicone pouch but neither a fibrotic infiltration into this coner nor ureteral stenosis was noted. Histological investigation of these animals in comparison with the control group showed effective protection by the silicone cover. Long-term results of experiments in larger animals well show whether thie procedure might be applied clinically.
 ...
PMID:Ureteric displacement into a silicone cover as protection from an induced retroperitoneal fibrosis: a preliminary report of experiments in rats. 726 6

1. The present study was designed to characterize the adenosine receptors involved in the relaxation of the pig intravesical ureter, and to investigate the action of adenosine on the non adrenergic non cholinergic (NANC) excitatory ureteral neurotransmission. 2. In U46619 (10(-7) M)-contracted strips treated with the adenosine uptake inhibitor, nitrobenzylthioinosine (NBTI, 10(-6) M), adenosine and related analogues induced relaxations with the following potency order: 5'-N-ethylcarboxamidoadenosine (NECA) = 5'-(N-cyclopropyl)-carboxamidoadenosine (CPCA) = 2-chloroadenosine (2-CA) > adenosine > cyclopentyladenosine (CPA) = N6-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide (IB-MECA) = 2-[p-(carboxyethyl)-phenylethylamino]-5'-N-ethylcarboxamidoaden os ine (CGS21680). 3. Epithelium removal or incubation with indomethacin (3 x 10(-6) M) and L-N(G)-nitroarginine (L-NOARG, 3 x 10(-5) M), inhibitors of prostanoids and nitric oxide (NO) synthase, respectively, failed to modify the relaxations to adenosine. 4. 1,3-dipropyl-8-cyclopentylxanthine (DPCPX, 10(-8) M) and 4-(2-[7-amino-2-(2-furyl) [1,2,4]-triazolo[2,3-a][1,3,5]triazin-5-ylamino]ethyl)phenol (ZM 241385, 3 x 10(-8) M and 10(-7) M), A1 and A2A receptor selective antagonists, respectively, did not modify the relaxations to adenosine or NECA. 8-phenyltheophylline (8-PT, 10(-5) M) and DPCPX (10(-6) M), which block A1/A2-receptors, reduced such relaxations. 5. In strips treated with guanethidine (10(-5) M), atropine (10(-7) M), L-NOARG (3 x 10(-5) M) and indomethacin (3 x 10(-6) M), both electrical field stimulation (EFS, 5 Hz) and exogenous ATP (10(-4) M) induced contractions of preparations. 8-PT (10(-5) M) increased both contractions. DPCPX (10(-8) M), NECA (10(-4) M), CPCA, (10(-4) M) and 2-CA (10(-4) M) did not alter the contractions to EFS. 6. The present results suggest that adenosine relaxes the pig intravesical ureter, independently of prostanoids or NO, through activation of A2B-receptors located in the smooth muscle. This relaxation may modulate the ureteral NANC excitatory neurotransmission through a postsynaptic mechanism.
 ...
PMID:A2B adenosine receptors mediate relaxation of the pig intravesical ureter: adenosine modulation of non adrenergic non cholinergic excitatory neurotransmission. 1019 77

Imidazoline receptor agonists such as moxonidine and rilmenidine increase sodium excretion whether administered within the central nervous system, intravenously, or directly into the renal artery. To determine if this natriuresis was mediated by a direct renal effect and was independent of the renal sympathetic nerves, we used two different preparations in the pentobarbital-anesthetized rat. In the first series of studies, rats were unilaterally nephrectomized 7 to 10 days before the experiment. On the day of the experiment, the remaining kidney was denervated (surgical and 10% phenol/ 95% ethyl alcohol) or sham treated. The effect of an intravenous infusion of rilmenidine was determined. Rilmenidine (10 nmol/kg/minute) decreased blood pressure and increased urine flow rate and sodium excretion in the sham- but not the denervation-treated rats. The response to furosemide (5.05 nmol/kg/minute) remained intact following denervation. We then used a two-kidney rat model that allowed for separate urine collection from each ureter. We used low infusion rates of moxonidine directly into the left renal artery. An increase in urine flow rate from the left but not the right kidney would suggest a direct renal action. Low infusion rates of moxonidine (10, 30 nmol/kg/minute) increased urine flow rate similarly from both ureters. A low infusion rate of furosemide (9.1 nmol/kg/minute) into the left renal artery increased urine flow rate only from the left ureter. The failure of moxonidine to increase urine flow rate selectively only in the left kidney indicated the agonist acts at an extrarenal site to increase urine flow rate from both kidneys equally. The complete attenuation of the response to rilmenidine indicates the importance of the renal nerves and suggests that the extrarenal site is most probably the central nervous system. Collectively, these studies do not support a direct renal action of imidazoline agonists in producing natriuresis.
 ...
PMID:Apparent absence of direct renal effect of imidazoline receptor agonists. 1502 2

We describe a unique solitary kidney with duplex collecting system and vascular variation observed in an 86-year-old White male formaldehyde- and phenol-fixed cadaver during routine academic dissection. The left renal fossa was empty with an intact adrenal gland, and the right renal fossa contained a fused renal mass with apparent polarity between the superior and inferior regions and two renal pelves converging into a single ureter. There were three right renal arteries supplying the renal mass; the superior and middle arteries were noted to be postcaval and the inferior artery was precaval. There were also two right renal veins draining into the inferior vena cava and following a regional distribution with the superior vein draining the inferior portion of the renal mass. Despite generally being asymptomatic, the detection of renal anatomical variants is clinically important for appropriate patient management and surgical interventions.
 ...
PMID:A case of solitary kidney with duplex collecting systems and renal vascular variants in an adult male cadaver. 3274 48